| Code: MTA8346 | Publication Date: Sep 2025 |
For detailed forecasts, data tables, and competitive benchmarking,
Explore the full Global Pruritus Market.
Pruritus Market is anticipated to flourish due to several growth factors which include the rising prevalence of chronic skin disorders, increasing geriatric population, growing awareness about dermatological health, and advancements in therapeutic and topical treatments.
Pruritus Market is growing steadily with robust trends such as the development of targeted therapies and biologics for chronic itch conditions. One major trend is the increasing adoption of non-invasive topical formulations and combination therapies that is driving growth. Further, the focus is emphasizing on over-the-counter pruritus management products and digital health platforms for dermatology care is shaping the market. Further, the personalized treatment approaches are gaining traction.
Pruritus Market is developing over the years with advancements in biologic drugs, JAK inhibitors, and novel anti-pruritic therapies. As the companies started investing in clinical trials for innovative treatments targeting chronic and systemic itch, the demand of pruritus is on high. Expansion of dermatology clinics and tele dermatology services is boosting accessibility. Further, the strategic collaborations and partnerships are increasing to enhance drug pipelines and improve patient care.
Below is a comprehensive list of the leading market players driving growth in this sector:
| Company Name | Sanofi S.A. |
|---|---|
| Established Year | 1973 |
| Headquarters | Paris, France |
| Official Website | Click Here |
This company develops therapies for dermatology and pruritus management and mainly focuses on innovative treatments and global patient access.
| Company Name | Pfizer Inc. |
|---|---|
| Established Year | 1849 |
| Headquarters | New York, United States |
| Official Website | Click Here |
This company manufactures pharmaceutical treatments for skin disorders and pruritus and emphasizes research, efficacy, and safety in therapies.
| Company Name | AbbVie Inc. |
|---|---|
| Established Year | 2013 |
| Headquarters | North Chicago, United States |
| Official Website | Click Here |
This company provides biologic therapies for chronic dermatological conditions and focuses on innovation and improving patient outcomes.
| Company Name | Novartis AG |
|---|---|
| Established Year | 1996 |
| Headquarters | Basel, Switzerland |
| Official Website | Click Here |
This company offers treatments for dermatology and pruritus conditions and prioritizes research, clinical trials, and global availability.
| Company Name | Regeneron Pharmaceuticals Inc. |
|---|---|
| Established Year | 1988 |
| Headquarters | Tarrytown, United States |
| Official Website | Click Here |
This company develops therapies targeting inflammatory and pruritic conditions and focuses on biologics and advanced treatment options.
| Company Name | Johnson & Johnson |
|---|---|
| Established Year | 1886 |
| Headquarters | New Brunswick, United States |
| Official Website | Click Here |
This company supplies dermatology solutions including pruritus therapies and emphasizes innovative and patient-centric treatments.
| Company Name | Leo Pharma A/S |
|---|---|
| Established Year | 1908 |
| Headquarters | Ballerup, Denmark |
| Official Website | Click Here |
This company manufactures dermatology treatments for chronic itch and skin disorders and focuses on research-driven and effective therapies.
| Company Name | Galderma S.A. |
|---|---|
| Established Year | 1981 |
| Headquarters | Lausanne, Switzerland |
| Official Website | Click Here |
This company provides topical and systemic therapies for pruritus management and emphasizes innovation and global dermatology solutions.